InvestSMART

Algorae Pharmaceuticals Limited (ASX: 1AI) - Announcements

Current share price for 1AI : $0.013 0 (4%)+

ASX company news and announcements for Algorae Pharmaceuticals Limited (1AI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Algorae Pharmaceuticals Limited (1AI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Algorae Pharmaceuticals Limited (1AI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Algorae Pharmaceuticals Limited (1AI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Application for quotation of securities - 1AI 19 Feb 2026 6:04PM $0.018 $0.013 fallen by 27.78%
$26 Cleansing Notice 13 Feb 2026 6:06PM $0.020 $0.013 fallen by 35%
$26 Application for quotation of securities - 1AI 13 Feb 2026 6:03PM $0.020 $0.013 fallen by 35%
$26 Algorae Signs License and Supply Agreement with Cadila 9 Feb 2026 9:02AM $0.023 $0.013 fallen by 43.48%
$26 1AI Corporate Presentation 3 Feb 2026 9:04AM $0.020 $0.013 fallen by 35%
$26 Application for quotation of securities - 1AI 2 Feb 2026 6:55PM $0.020 $0.013 fallen by 35%
$26 Quarterly Activities Report /Appendix 4C Cash Flow Statement 28 Jan 2026 8:59AM $0.022 $0.013 fallen by 40.91%
$26 $3 million Debt Facility Secured with ScotPac 21 Jan 2026 9:01AM $0.018 $0.013 fallen by 27.78%
$26 Change of Director's Interest Notice - DH, BL 22 Dec 2025 9:52AM $0.015 $0.013 fallen by 13.33%
$26 Notification regarding unquoted securities - 1AI 22 Dec 2025 9:33AM $0.015 $0.013 fallen by 13.33%
$26 Application for quotation of securities - 1AI 19 Dec 2025 6:01PM $0.015 $0.013 fallen by 13.33%
$26 Loyalty Option Offer Results 19 Dec 2025 8:59AM $0.015 $0.013 fallen by 13.33%
$26 AlgoraeOS v2 Identifies 90 Drug Combination Candidates 12 Dec 2025 9:00AM $0.015 $0.013 fallen by 13.33%
$26 Algorae Receives $384,466.78 R&D Tax Incentive Refund 10 Dec 2025 8:57AM $0.015 $0.013 fallen by 13.33%
$26 Peter Mac Testing Validates AlgoraeOS - v2 Launched 5 Dec 2025 8:57AM $0.014 $0.013 fallen by 7.14%
$26 Loyalty Options Offer Open and Shareholder Letters 2 Dec 2025 9:04AM $0.014 $0.013 fallen by 7.14%
$26 Update - Proposed issue of securities - 1AI 27 Nov 2025 5:22PM $0.015 $0.013 fallen by 13.33%
$26 Application for quotation of securities - 1AI 27 Nov 2025 5:07PM $0.015 $0.013 fallen by 13.33%
$26 Algorae Signs Distribution Agreement with Dr. Reddy's 27 Nov 2025 9:00AM $0.013 $0.013 fallen by 0%
$26 Proposed issue of securities - 1AI 17 Nov 2025 9:42AM $0.009 $0.013 risen by 44.44%
$26 Proposed issue of securities - 1AI 17 Nov 2025 9:30AM $0.009 $0.013 risen by 44.44%
$26 Loyalty Options Offer 17 Nov 2025 9:18AM $0.009 $0.013 risen by 44.44%
$26 Prospectus - Loyalty Options Offer 17 Nov 2025 9:12AM $0.009 $0.013 risen by 44.44%
$26 AlgoraeOS Version 2 AI Platform Launched 10 Nov 2025 8:58AM $0.009 $0.013 risen by 44.44%
$26 Cleansing Notice 7 Nov 2025 4:24PM $0.009 $0.013 risen by 44.44%

51 - 75 of 186 results

Page 3 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.